Clinical Trials Logo

Filter by:
NCT ID: NCT04329416 Completed - Thoracic Surgery Clinical Trials

Insertion Depth of Left-sided Double-lumen Tube: a New Predictive Formula

Start date: May 7, 2019
Phase: N/A
Study type: Interventional

The authors developed a formula for predicting the accurate depth of DLT insertion into the appropriate bronchus based on height as follows [The predicted insertion depth of left DLT (cm) equals 0.249 × (BH)0.916] [R]. That pilot study showed comparable correlations between five formulae [Brodsky et al, Bahk and Oh R, Takita et al, Chow et al, Lin]. However, that formula developed has not been validated yet. We hypothesized that previously published formula would predict the accurate depth of left-sided DLT insertion. We aimed to investigate the efficacy of this formula to estimate the optimum insertion depth of the DLT using a flexible bronchoscope and decrease the incidence of DLT displacement into the appropriate bronchus, the need for bronchoscopic adjustment, and complications including soreness of throat and mucosal injury.

NCT ID: NCT04312971 Completed - Cardiac Surgery Clinical Trials

Norepinephrine Infusion During Cardiopulmonary Bypass

Norcal
Start date: May 6, 2020
Phase: N/A
Study type: Interventional

The primary objective is to test the efficacy and safety of the accuracy of continuous intravenous infusion of norepinephrine during cardiopulmonary bypass (CPB) on the prevention of hyperlactatemia after cardiac surgery. "Efficacy" would be tested with measurement of the postoperative changes in lactic acid level over time from the baseline value before induction of general anesthesia. "safety" would be tested with observing the post-cardiotomy need for inotropic and vasopressor support, the incidence of postoperative acute kidney injury (AKI), changes in cardiac troponin level (CnTnI), and signs of ischemic splanchnic injury.

NCT ID: NCT04303390 Completed - Clinical trials for Surgical Site Infection

24 Vs 48 Hours of Cefazolin or Cefuroxime as Prophylaxis

Start date: February 6, 2018
Phase: Phase 4
Study type: Interventional

A randomized control trial studying the effect of prophylactic antibiotics to reduce surgical site infections following cardiac surgery in adults using 1st generation cephalosporin (Cefazolin) or 2nd generation cephalosporin (Cefuroxime).

NCT ID: NCT04301336 Completed - Sickle Cell Disease Clinical Trials

Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia

Start date: November 1, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of the present study is comparing the effectiveness of different treatment regimens for investigating the therapeutic potential for each one in management of Vaso-occlusive pain in pediatric sickle cell disease. In addition, investigators apply the Cost-effectiveness analysis (CEA) as a form of economic analysis that compares the relative costs and outcomes (effects) for different treatment regimens on vaso-occlusive painful crisis.

NCT ID: NCT04292314 Completed - Oxidative Stress Clinical Trials

Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia

Start date: November 1, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of the present study is evaluating the strength of combination therapy of hydroxy urea, omega 3, nigella sativa and honey on antioxidant-oxidant status (OXIDATIVE STRESS) in response to reactive oxygen species production (LIPID PEROXIDATION) and their effect on iron intoxication (IRON CHELATION) in pediatric major thalassemia.

NCT ID: NCT04285255 Completed - Analgesia Clinical Trials

Quality of Recovery Following Opioids Free Anaesthesia in Laparoscopic Sleeve Gastrectomy

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

Laparoscopic sleeve gastrectomy is widely employed nowadays. Multimodal analgesia approach is implemented within the enhanced recovery protocol in our facility to improve participants' recovery. Due to side effects of narcotics, the may adversely affect the quality of recovery, the investigators intended to test the efficacy of opioids free anaesthesia on the quality of recovery and postoperative narcotic use.

NCT ID: NCT04271618 Completed - Cerebral Palsy Clinical Trials

Modulation of Sagittal Spinal Geometry in Children With Cerebral Palsy

Start date: February 12, 2020
Phase: N/A
Study type: Interventional

The aim of this study will be to evaluate the the effect of Thera Togs soft orthotic undergarment on modulation of the spinal geometry and mobility in sagittal plan in children with spastic diplegic cerebral palsy.

NCT ID: NCT04269798 Completed - Cerebral Palsy Clinical Trials

The Effect of Functional Electrical Stimulation on Gait and Balance in Children With Hemiplegic Cerebral Palsy

Start date: February 11, 2020
Phase: N/A
Study type: Interventional

The aim of this study will be to evaluate the effect of FES on stimulation of the anterior tibial group by using the WalkAide foot drop stimulator on improving walking and balance abilities in children with hemiplegic CP.

NCT ID: NCT04264364 Completed - Obesity Clinical Trials

ESG vs LSG: Short-term Nutritional Outcomes

Start date: June 16, 2019
Phase:
Study type: Observational

To assess endoscopic sleeve gastroplasty in comparison to laparoscopic sleeve gastrectomy before and 3 months after the procedure in terms of multiple nutrition-related factors, quality of life, weight and other related parameters.

NCT ID: NCT04257981 Completed - Clinical trials for Cerebral Palsy Infantile

Effect of Transcranial Direct Current Stimulation on Upper Extremity of Children With Hemiparesis

Start date: January 3, 2020
Phase: N/A
Study type: Interventional

Purpose: The aim of the study is to determine the combined effect of transcranial direct current stimulation (tDCS) and activities in virtual reality on the functional recovery of the upper extremity function of the children with hemiparesis. Subjects: Forty children with infantile stroke with age group between (6-12 years) will be divided into two groups, the experimental group will receive tDCS plus VR while the control group will receive sham tDCS plus VR. All the children will receive tDCS for 30minutes with 1.5 mA intensity over the dominant motor cortex. Both groups will be treated for three times a week for 6 weeks. Instrumentation: The the Fugl-Meyer assessment, motricity index, and Modified Barthel index will be used to assess the dependent variables after the intervention.